S-1/A Filing

SOLENO THERAPEUTICS INC CIK: 1484565

Filing Information

Form Type	S-1/A
Accession Number	`0001193125-16-685325`
Period End Date	20160630
Filing Date	20160818
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	capn-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 111 Cash Flow Statement 151 Stockholders Equity 31 Comprehensive Income 1

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.02M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.76M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	485,202.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.76M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.02M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$156.13K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$288.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$20.00K	USD	Point-in-time
Inventory	`InventoryNet`	$551.01K	USD	Point-in-time
Inventory	`InventoryNet`	$774.00K	USD	Point-in-time
Inventory	`InventoryNet`	$109.34K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$157.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$252.27K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$167.64K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.76M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$57.61K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$85.75K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$118.00K	USD	Point-in-time
Goodwill	`Goodwill`	$718.00K	USD	Point-in-time
Goodwill	`Goodwill`	$718.00K	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	-	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$867.00K	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$916.81K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$76.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$76.34K	USD	Point-in-time
Total assets	`Assets`	$5.54M	USD	Point-in-time
Total assets	`Assets`	$8.40M	USD	Point-in-time
Total assets	`Assets`	$8.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$957.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$695.06K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$986.80K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$201.46K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$944.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.63M	USD	Point-in-time
Line of credit and accrued interest	`LinesOfCreditCurrent`	$101.53K	USD	Point-in-time
Line of credit and accrued interest	`LinesOfCreditCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.19M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$109.40K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$6.77K	USD	Point-in-time
Common stock	`CommonStockValue`	$14.02K	USD	Point-in-time
Common stock	`CommonStockValue`	$15.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$89.46M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$95.54M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$59.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-86.25M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$3.22M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$2.61M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-34.20M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.54M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.40M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.20M	USD	Point-in-time

Income Statement 111 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	-	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$387.56K	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$391.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$119.00K	USD	2 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$838.00K	USD	2 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$97.00K	USD	1 Quarter
Government grant revenue	`RevenueFromGrants`	$219.92K	USD	Annual
Total revenue	`Revenues`	-	USD	Annual
Total revenue	`Revenues`	$607.47K	USD	Annual
Cost of product revenue	`CostOfRevenue`	$352.68K	USD	Annual
Cost of product revenue	`CostOfRevenue`	$428.00K	USD	1 Quarter
Cost of product revenue	`CostOfRevenue`	$40.00K	USD	2 Qtrs
Cost of product revenue	`CostOfRevenue`	$889.00K	USD	2 Qtrs
Cost of product revenue	`CostOfRevenue`	$22.00K	USD	1 Quarter
Cost of product revenue	`CostOfRevenue`	-	USD	Annual
Gross profit (loss)	`GrossProfit`	$-37.00K	USD	1 Quarter
Gross profit (loss)	`GrossProfit`	$75.00K	USD	1 Quarter
Gross profit (loss)	`GrossProfit`	$254.79K	USD	Annual
Gross profit (loss)	`GrossProfit`	-	USD	Annual
Gross profit (loss)	`GrossProfit`	$-51.00K	USD	2 Qtrs
Gross profit (loss)	`GrossProfit`	$79.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.24M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.06M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.33M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.54M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$772.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$1.11M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$1.74M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$506.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$252.36K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$577.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.14M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.45M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.67M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.72M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$5.55M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$3.41M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$5.16M	USD	Annual
Total expenses	`OperatingExpenses`	$12.41M	USD	Annual
Total expenses	`OperatingExpenses`	$7.66M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$3.12M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.45M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-7.71M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-12.16M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-5.47M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.04M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.16M	USD	Annual
Interest expense, net	`InterestExpense`	$1.00K	USD	2 Qtrs
Interest expense, net	`InterestExpense`	-	USD	1 Quarter
Interest expense, net	`InterestExpense`	-	USD	2 Qtrs
Interest expense, net	`InterestExpense`	-	USD	1 Quarter
Interest expense, net	`InterestExpense`	-	USD	Annual
Interest expense, net	`InterestExpense`	$4.13M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.08K	USD	Annual
Interest income	`InvestmentIncomeInterest`	-	USD	Annual
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$3.94M	USD	Annual
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$-4.92M	USD	1 Quarter
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$-1.12M	USD	2 Qtrs
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$515.86K	USD	Annual
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$1.25M	USD	2 Qtrs
Change in fair value of warrants liabilities (expense)	`FairValueAdjustmentOfWarrants`	$47.00K	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	-	USD	2 Qtrs
Cease-use expense	`GainLossOnContractTermination`	-	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	-	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	$-94.00K	USD	2 Qtrs
Other expense	`OtherNonrecurringExpense`	$16.00K	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	-	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	-	USD	2 Qtrs
Other expense	`OtherNonrecurringExpense`	$7.24K	USD	Annual
Other expense	`OtherNonrecurringExpense`	$18.00K	USD	2 Qtrs
Other expense	`OtherNonrecurringExpense`	$183.56K	USD	Annual
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	-	USD	1 Quarter
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	$3.05M	USD	Annual
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	$3.05M	USD	2 Qtrs
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	-	USD	Annual
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	-	USD	1 Quarter
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	-	USD	2 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$1.01M	USD	2 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$4.92M	USD	1 Quarter
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-4.30M	USD	2 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-63.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-3.51M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-13.24M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-15.91M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$1.88M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-9.77M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-6.70M	USD	2 Qtrs
Basic and diluted net loss per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.69	USD	Annual
Basic and diluted net loss per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-10.42	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.25	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.35	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.44	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.23	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.25	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.23	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.35	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.44	USD	2 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.43M	shares	Annual
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.27M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.24M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.53M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.52M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.16M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.24M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.16M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.63M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.53M	shares	1 Quarter

Cash Flow Statement 151 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.91M	USD	Annual
Net loss	`NetIncomeLoss`	$1.88M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.70M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$55.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$108.23K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$31.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$28.52K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$942.37K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$345.44K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$354.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$602.00K	USD	2 Qtrs
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	2 Qtrs
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.73K	USD	Annual
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$-1.12M	USD	2 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$3.94M	USD	Annual
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$515.86K	USD	Annual
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$1.25M	USD	2 Qtrs
Non-cash interest expense relating to convertible promissory notes & amortization of discount on notes	`AmortizationOfDebtDiscountPremium`	$4.13M	USD	Annual
Non-cash interest expense relating to convertible promissory notes & amortization of discount on notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	$3.05M	USD	2 Qtrs
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	-	USD	Annual
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	$3.05M	USD	Annual
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	-	USD	2 Qtrs
Noncash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	-	USD	Annual
Noncash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$183.32K	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$27.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	2 Qtrs
Non-cash interest expense relating to line of credit	`LineOfCreditFacilityPeriodicPaymentInterest`	$1.53K	USD	Annual
Non-cash interest expense relating to line of credit	`LineOfCreditFacilityPeriodicPaymentInterest`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$156.13K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$132.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-149.60K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$109.34K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$223.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$169.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$441.67K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$167.12K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$59.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-84.63K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-10.00K	USD	2 Qtrs
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$76.34K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	-	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$401.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$211.94K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$353.90K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$334.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.19M	USD	Annual
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$617.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-689.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$72.81K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$64.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.02M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.48M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.30M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.06M	USD	2 Qtrs
Acquisition of Neoforce assets	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	$1.00M	USD	Annual
Acquisition of Neoforce assets	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	-	USD	Annual
Acquisition of BDDI asset (patent)	`PaymentsToAcquireIntangibleAssets`	$250.00K	USD	Annual
Acquisition of BDDI asset (patent)	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Increase in restricted cash	`IncreaseDecreaseInRestrictedCash`	$15.00K	USD	2 Qtrs
Increase in restricted cash	`IncreaseDecreaseInRestrictedCash`	-	USD	Annual
Increase in restricted cash	`IncreaseDecreaseInRestrictedCash`	$15.00K	USD	Annual
Increase in restricted cash	`IncreaseDecreaseInRestrictedCash`	-	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$39.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$55.78K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.68K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-31.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.32M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-30.68K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-39.00K	USD	2 Qtrs
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$294.00K	USD	2 Qtrs
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$293.57K	USD	Annual
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$70.00K	USD	2 Qtrs
Proceeds from issuance of common stock to Aspire Capital	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock to Aspire Capital	`ProceedsFromIssuanceOfCommonStock`	$1.43M	USD	Annual
Proceeds from sale of Series A preferred convertible stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	2 Qtrs
Proceeds from sale of Series A preferred convertible stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$4.23M	USD	Annual
Proceeds from sale of Series A preferred convertible stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from sale of Series A preferred convertible stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$5.07M	USD	2 Qtrs
Repayment of credit line	`RepaymentsOfLinesOfCredit`	-	USD	2 Qtrs
Repayment of credit line	`RepaymentsOfLinesOfCredit`	$102.00K	USD	2 Qtrs
Repayment of credit line	`RepaymentsOfLinesOfCredit`	$101.53K	USD	Annual
Repayment of credit line	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Proceeds from issuance of preferred stock warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$1.95K	USD	Annual
Proceeds from issuance of preferred stock warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	Annual
Proceeds from issuance of convertible notes payable	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible notes payable	`ProceedsFromConvertibleDebt`	$2.49M	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$100.00K	USD	Annual
Proceeds from Initial Public Offering	`ProceedsFromIssuanceInitialPublicOffering`	$10.73M	USD	Annual
Proceeds from Initial Public Offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$2.12M	USD	Annual
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$575.18K	USD	Annual
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$530.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.07M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.20M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.66M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.16M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.99M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-427.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$6.69M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.46M	USD	Annual
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.53M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Series A preferred convertible stock transaction costs included in Accounts Payable	`TransactionCostsIncludedinAccountsPayable`	-	USD	Annual
Series A preferred convertible stock transaction costs included in Accounts Payable	`TransactionCostsIncludedinAccountsPayable`	$71.49K	USD	Annual
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	$23.81M	USD	Annual
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	$2.22M	USD	2 Qtrs
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Patent costs included in Accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$450.00K	USD	2 Qtrs
Patent costs included in Accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	2 Qtrs
Shares issued as consideration for BDDI patent purchase	`StockIssued1`	-	USD	Annual
Shares issued as consideration for BDDI patent purchase	`StockIssued1`	$112.40K	USD	Annual
Shares issued as consideration for BDDI patent purchase	`StockIssued1`	$112.00K	USD	2 Qtrs
Shares issued as consideration for BDDI patent purchase	`StockIssued1`	-	USD	2 Qtrs
BDDI patent purchase consideration included in accrued liabilities	`BusinessCombinationConsiderationTransferredContingentConsiderationAccrued`	$200.00K	USD	Annual
BDDI patent purchase consideration included in accrued liabilities	`BusinessCombinationConsiderationTransferredContingentConsiderationAccrued`	-	USD	Annual
Reduction in initial public offering costs payable	`ReductionInInitialPublicOfferingCostsPayable`	$45.00K	USD	2 Qtrs
Reduction in initial public offering costs payable	`ReductionInInitialPublicOfferingCostsPayable`	-	USD	2 Qtrs
Cashless exercise of 2010 and 2012 warrants	`NoncashTransactionExerciseofWarrants`	-	USD	Annual
Cashless exercise of 2010 and 2012 warrants	`NoncashTransactionExerciseofWarrants`	-	USD	2 Qtrs
Cashless exercise of 2010 and 2012 warrants	`NoncashTransactionExerciseofWarrants`	$13.00	USD	Annual
Cashless exercise of 2010 and 2012 warrants	`NoncashTransactionExerciseofWarrants`	$13.00K	USD	2 Qtrs
Contribution of Series B warrants	`ContributionofWarrants`	$3.33K	USD	Annual
Contribution of Series B warrants	`ContributionofWarrants`	-	USD	Annual
Initial public offering costs accrued and included in accounts payable	`InitialPublicOfferingCostsIncludedInAccountsPayable`	-	USD	Annual
Initial public offering costs accrued and included in accounts payable	`InitialPublicOfferingCostsIncludedInAccountsPayable`	$575.18K	USD	Annual
Beneficial conversion feature related to the warrants to purchase shares of convertible preferred stock in connection with convertible promissory notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	$1.72M	USD	Annual
Beneficial conversion feature related to the warrants to purchase shares of convertible preferred stock in connection with convertible promissory notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Issuance of warrants for the purchase of convertible preferred stock in connection with notes payable	`IssuanceOfWarrantsInConnectionWithNotesPayable`	-	USD	Annual
Issuance of warrants for the purchase of convertible preferred stock in connection with notes payable	`IssuanceOfWarrantsInConnectionWithNotesPayable`	$966.98K	USD	Annual

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balances at beginning	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$3.22M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$2.61M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$-34.20M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$942.37K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$345.44K	USD	Annual
Conversion of preferred stock to common stock in IPO	`ConversionOfStockAmountIssued1`	$23.81M	USD	Annual
Conversion of preferred stock to common stock in IPO	`ConversionOfStockAmountIssued1`	$2.22M	USD	2 Qtrs
Conversion of preferred stock to common stock in IPO	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Stock warrant liability reclassification	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$1.22M	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$293.57K	USD	Annual
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.85M	USD	Annual
Beneficial conversion feature in connection with related party convertible promissory notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$1.72M	USD	Annual
Contribution of Series B warrants	`AdjustmentstoAdditionalPaidinCapitalWarrantsContributed`	$3.33K	USD	Annual
Issuance of shares in conjunction with BDDI asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$112.40K	USD	Annual
Issuance of shares in conjunction with BDDI asset purchase (shares)	`StockIssuedDuringPeriodSharesPurchaseOfAssets`	40,000.00	shares	Point-in-time
Issuance of shares in conjunction with BDDI asset purchase (shares)	`StockIssuedDuringPeriodSharesPurchaseOfAssets`	10,000.00	shares	Point-in-time
Deferred IPO costs	`AdjustmentstoAdditionalPaidinCapitalStockIssuedDeferredIssuanceCosts`	$1.83M	USD	Annual
Issuance of shares to Aspire Capital	`StockIssuedDuringPeriodValueAcquisitions`	$183.32K	USD	Annual
Sales of shares through Aspire ATM vehicle	`StockIssuedDuringPeriodValueNewIssuesUnderTheAtTheMarketProgram`	$1.43M	USD	Annual
Issuance of Series A Convertible Preferred shares(net of transaction costs of $396,343)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments`	$4.16M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.91M	USD	Annual
Net loss	`NetIncomeLoss`	$1.88M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.70M	USD	2 Qtrs
Balances at end	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$3.22M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$2.61M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$-34.20M	USD	Point-in-time

Comprehensive Income 1 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock in IPO, discounts & commission	`DiscountAndCommissionOnIssuanceOfShares`	$861.95K	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.